Literature DB >> 9198187

The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.

T S Edgington1, C D Dickinson, W Ruf.   

Abstract

Cell surface tissue factor (TF), the major in vivo initiator of coagulation, activates coagulation by binding and allosteric activation of the serine protease factor. VIIa (VIIa). A graphic scheme to account for function of this initial bimolecular activation complex has emerged from the integration of structural with functional analyses. The VIIa light chain, specifically the Gla and EGF-1 domains, form extended hydrophobic contacts with TF which account for most of the free energy of binding. These contacts tether VIIa and facilitate interactions of the protease domain with TF necessary for induction of protease function. Several contact residues in the VIIa protease domain-TF interface are involved in the activation of VIIa by complex allosteric effects. Macromolecular substrate zymogens interact with both the VIIa protease domain and the carboxyl-terminal module of TF. Docking of the VIIa Gla-domain to the latter region of TF appears to contribute to substrate assembly. The current data suggest an extended embrace between TF and VIIa to form the bimolecular enzyme TF.VIIa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198187

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.

Authors:  L Perera; T A Darden; L G Pedersen
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

2.  Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.

Authors:  J A Kolkman; P J Lenting; K Mertens
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

3.  So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.

Authors:  T S Edgington
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

5.  Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.

Authors:  Michał Zabczyk; Saulius Butenas; Ilona Palka; Jadwiga Nessler; Anetta Undas
Journal:  Pol Arch Med Wewn       Date:  2010-09

Review 6.  Tissue factor: a key molecule in hemostatic and nonhemostatic systems.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

7.  Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.

Authors:  Amir Mashayekhi; Shirin Shahbazi; Mirdavood Omrani
Journal:  Iran J Biotechnol       Date:  2018-04-18       Impact factor: 1.671

8.  Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities.

Authors:  Mohammad A Mohammad; John Greenman; Anthony Maraveyas; Camille Ettelaie
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.